cterminal telopeptide ctx also known carboxyterminal collagen crosslinks cterminal telopeptide fibrillar collagens collagen type type ii used biomarker serum measure rate bone turnover useful assisting clinicians determine patients nonsurgical treatment response well evaluate patients risk developing complications healing following surgical test used detect ctx marker called serum crosslaps specific bone resorption test currently early link bisphosphonate use impaired bone physiology strong inhibition osteoclast function precipitated bisphosphonate therapy lead inhibition normal bone turnover leading impaired wound healing following trauma dental surgery even spontaneous nonhealing bone exposure bisphosphonates preferentially deposited bone high turnover rates possible levels bisphosphonate within jaw bones selectively advent implant dentistry dental patients undergoing therapies oral cavity involve bone healing surgical implant placement bone grafting procedures order evaluate risk osteonecrosis patient taking bisphosphonates use ctx biomarker introduced although number surrogate biomarkers exist measuring metabolic products bone resorption serum ctx marker chosen highly correlated bone turnover rate already available detection laboratory test carried major lab testing ctx test measures presence concentration crosslink peptide sequence type collagen found among tissues bone specific peptide sequence relates bone turnover portion cleaved osteoclasts bone resorption serum levels therefore proportional osteoclastic activity time blood sample serum levels healthy patients taking bisphosphonates tends hover pgml even though laboratory normal ranges said pgml pgml normal range accurate related osteoporosis population actual normal values usually well pgml commonly pgml pgml patients taking bisphosphonates lower values represent varying degrees suppression normal bone turnover sometimes also called bone remodeling bone patients placed drug holiday exhibit marked improvements serum ctx values one study patients showed improvement pgml months rate pgml initially urinary ctx levels sought proved offer greater value urinary ntx tests suffered large spontaneous fluctuations unrelated therapy intervention therefore largely contrast monoclonal antibody test detecting serum ctx levels features minimal spontaneous disruption yet remarkable change antiresorptive therapy making serum ctx assay highly sensitive httpsenwikipediaorgwikicrosslaps